Alcolase raises $1.6M (Denmark, May 2026)
$1.6M
€1.5MReach the investors backing rounds like this
Backed by Ada Ventures, Delphinus Venture Capital +2 more · verified emails and LinkedIn on Datapile
Generated social card
Headline
Alcolase raises €1.5M to tackle alcohol intolerance with enzyme technology - Tech.eu
About
Alcolase is developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream.
Article summary
Alcolase raises €1.5M to tackle alcohol intolerance with enzyme technology Tech.eu
Founder
Mikkel Precht
CEO and Co-founder
Investors · 4
2 hiddenRelated rounds
| Oct 08, 2026 | TODAY | $2.8M | Seed | Denmark |
| Oct 07, 2026 | Pandektes | $14.8M | Series A | Denmark |
| Oct 05, 2026 | Rodinia | $4.5M | — | Denmark |
| Oct 02, 2026 | Breye Therapeutics | $73.0M | — | Denmark |
149 investors back startups in Denmark
You just read who funded Alcolase. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.